Blood pressure elevation with ketamine and esketamine in depression: a systematic review and meta-analysis of randomised trials
Year: 2026
Type: review
Study design: Study Protocol
Abstract: Review title: Blood pressure elevation with ketamine and esketamine in depression: a systematic review and meta-analysis of randomised trials Type and method of review: Meta analysis Stage of review at time of this submission: Review ongoing — the protocol has been finalised and the peer-reviewed search prepared; formal screening not yet started. Review question: In Adults with depression (including treatment-resistant depression), what is the effect of Ketamine or esketamine (any route) compared with Placebo or active control on Blood pressure elevation (mean change in systolic and diastolic BP) (primary); proportion with clinically significant hypertension (secondary)? Searches: The following sources will be searched: Europe PMC (PubMed, MEDLINE & preprints), PubMed / MEDLINE, Embase, Cochrane CENTRAL, Scopus, Google Scholar. Additional records may be imported from other databases. No date or language restrictions are applied unless otherwise stated. The search strategy underwent peer review (PRESS) before execution. Condition or domain being studied: Adults with depression (including treatment-resistant depression) Participants / population: Adults with depression (including treatment-resistant depression) Intervention(s), exposure(s): Ketamine or esketamine (any route) Comparator(s) / control: Placebo or active control Types of study to be included: Inclusion criteria: Adults with major depressive disorder or treatment-resistant depression; Ketamine (intravenous, intramuscular, oral) or esketamine (intranasal); Compared with placebo or an active control; Randomised controlled trials reporting blood pressure outcomes; Full-text article published in English. Exclusion criteria: Anaesthetic or analgesic use of ketamine only; Non-randomised studies; Reviews, editorials, letters, case reports or conference abstracts; Overlapping samples (the largest or most recent report is kept) Main outcome(s): Blood pressure elevation (mean change in systolic and diastolic BP) (primary); proportion with clinically significant hypertension (secondary) Data extraction (selection and coding): Two reviewers will independently screen titles/abstracts and full texts, blinded to each other’s decisions, and extract data in duplicate using a standardised, piloted form. Disagreements will be resolved by discussion or a third reviewer. Risk of bias (quality) assessment: The risk of bias of each included study will be assessed independently by two reviewers using a study-design-appropriate tool. Disagreements will be resolved by consensus. Risk of bias in the review itself will be appraised with ROBIS. Strategy for data synthesis: Results will be synthesised narratively. Where studies are sufficiently homogeneous, effect estimates will be pooled in a meta-analysis using a fixed- or random-effects model as indicated by heterogeneity (I²). The certainty of the evidence will be rated using GRADE.
Source: Open Science Framework
Author: Karim Haffar
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225107814
